Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2013 3
2014 1
2016 2
2017 3
2018 1
2020 2
2021 3
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Aptamer-Based Immunotheranostic Strategies.
García Melián MF, Moreno M, Cerecetto H, Calzada V. García Melián MF, et al. Among authors: calzada v. Cancer Biother Radiopharm. 2023 May;38(4):246-255. doi: 10.1089/cbr.2022.0064. Epub 2023 Jan 5. Cancer Biother Radiopharm. 2023. PMID: 36603108 Review.
Sequence-dependent structural properties of B-DNA: what have we learned in 40 years?
da Rosa G, Grille L, Calzada V, Ahmad K, Arcon JP, Battistini F, Bayarri G, Bishop T, Carloni P, Cheatham Iii T, Collepardo-Guevara R, Czub J, Espinosa JR, Galindo-Murillo R, Harris SA, Hospital A, Laughton C, Maddocks JH, Noy A, Orozco M, Pasi M, Pérez A, Petkevičiūtė-Gerlach D, Sharma R, Sun R, Dans PD. da Rosa G, et al. Among authors: calzada v. Biophys Rev. 2021 Nov 13;13(6):995-1005. doi: 10.1007/s12551-021-00893-8. eCollection 2021 Dec. Biophys Rev. 2021. PMID: 35059023 Free PMC article. Review.
177Lu-DOTA-Bevacizumab: Radioimmunotherapy Agent for Melanoma.
Camacho X, Calzada V, Fernandez M, Alonso O, Chammas R, Riva E, Gambini JP, Cabral P. Camacho X, et al. Among authors: calzada v. Curr Radiopharm. 2017;10(1):21-28. doi: 10.2174/1874471009666161010155246. Curr Radiopharm. 2017. PMID: 27748184
Fab(nimotuzumab)-HYNIC-99mTc: Antibody Fragmentation for Molecular Imaging Agents.
Calzada V, García MF, Alonso-Martínez LM, Camachoc X, Goicochea E, Fernández M, Castillo AX, Díaz-Miqueli A, Iznaga-Escobar N, Montaña RL, Alonso O, Gambini JP, Cabral P. Calzada V, et al. Anticancer Agents Med Chem. 2016;16(9):1184-9. doi: 10.2174/1871520616666160310143828. Anticancer Agents Med Chem. 2016. PMID: 26961312
Synthesis and evaluation of (99m)Tc chelate-conjugated bevacizumab.
Camacho X, García MF, Calzada V, Fernández M, Porcal W, Alonso O, Gambini JP, Cabral P. Camacho X, et al. Among authors: calzada v. Curr Radiopharm. 2013 Mar;6(1):12-9. doi: 10.2174/1874471011306010003. Curr Radiopharm. 2013. PMID: 23035645
18 results